American Oncology Network, Inc. · OTC:AONC

American Oncology Network — Digital Transformation Opportunities — SPAC Merger (October 2022)

26 slides from American Oncology Network's SPAC merger presentation, Oct 6, 2022

  1. Slide 1: Investor Presentation October 2022

    Investor Presentation October 2022

  2. Slide 2: Disclaimer

    2 Disclaimer General This presentation is provided for information purposes only and has been prepared to assist interested parties in making their own evaluation with respect to a potential business combination (the “Potential Transaction”) involving Digital Transformation Opportunities Corp . (“DT

  3. Slide 3: Disclaimer (Cont.)

    3 Disclaimer (Cont.) Additional Information and Where You Can Find It In connection with the proposed Potential Transaction, DTOC intends to file with the SEC a proxy statement, which will be mailed (if and when available) to all DTOC stockholders once definitive, which will serve as a preliminary p

  4. Slide 4: Digital Transformation Opportunities Corp. Overview

    4 Digital Transformation Opportunities Corp. Overview ▪ Digital Transformation Opportunities Corp. (“DTOC”) completed its IPO in March 2021 with $333.5 million of cash in trust ▪ DTOC formed to merge with a healthcare business that has a proven business model and a strong value proposition ▪ Led by

  5. Slide 5: Why DTOC Chose to Partner with AON

    5 Why DTOC Chose to Partner with AON Scaled Oncology Network with Strong Historical Growth Track Record Fragmented Industry that is Large and Growing Entrepreneurial and Experienced Management Team Reputation for Clinical Excellence Compelling Value Proposition for Patients, Providers, and Payors We

  6. Slide 6: Transaction Overview

    6 45.0% 40.9% 7.4% 6.7% AON Equityholders SPAC Shareholders PIPE Investors SPAC Sponsor Transaction Overview Illustrative Sources & Uses 1) Reflects accrued p referred return on existing shareholder investments based on illustrative closing date of February 28, 2023. 2) Illustrative and subject to c

  7. Slide 7: Company Overview

    Company Overview Opportunities Corp. AON Digital Transformation AMERICAN ONCOLOGY NETWORK, LLC

  8. Slide 8: AON Leadership

    8 AON Leadership EXECUTIVE MANAGEMENT TEAM WITH A PROVEN TRACK RECORD OF INDUSTRY LEADERSHIP… Todd Schonherz Chief Executive Officer ▪ Previously, 10 years as COO of Florida Cancer Specialists and Research Institute (FCS), a leader in medical oncology & hematology ▪ Prior to FCS, 12 years with US On

  9. Slide 9: Scaled Oncology Network with Strong Growth Track Record

    9 AON has built an impressive footprint of 71 locations with 107 physicians across 24 practices and 18 states since AON commenced operations in September 2018 Scaled Oncology Network with Strong Growth Track Record …WITH PROVEN MOMENTUM AND DEMONSTRATED ABILITY TO CONTINUE EXPAN SION RAPIDLY GROWING

  10. Slide 10: Patient First approach and comprehensive offering

    10 “Patient First” approach and comprehensive offering ensures high quality and efficient patient service Revenue Cycle and Purchasing Information Technology Human Resources Exec and Senior Management Accounting, Compliance, and Legal Managed Care Contracting Credentialing Research Transitions Care

  11. Slide 11: Reputation for Clinical Excellence

    11 Reputation for Clinical Excellence AON has established a reputation for clinical excellence by following a standard care management process which results in delivering consistent, high - quality care across the platform …AND COMPREHENSIVE COMPLIANCE PROGRAM… …DRIVES TANGIBLE CLINICAL EXCELLENCE ~

  12. Slide 12: Strong Team-Oriented Culture

    12 Strong Team - Oriented Culture AON’s team - focused and values - driven culture promotes loyalty and trust from providers and staff, leading to strong clinical outcomes CONTINUOUSLY ALWAYS RESPECTFULLY EXCEED Support the Patient Do the Right Thing Engage Expectations Delivers results by providing

  13. Slide 13: Compelling Value Proposition to Patients, Providers, and Payors

    13 Compelling Value Proposition to Patients, Providers, and Payors AON’s platform provides a compelling value proposition for all stakeholders – patients, providers, and payors Patients ▪ Quality providers, continuous clinical improvements and ancillary services such as pathology, pharmacy, care man

  14. Slide 14: Fragmented Industry that is Large and Growing

    14 Fragmented Industry that is Large and Growing AON is well - positioned to take share in a rapidly growing, non - cyclical industry with increasing clinical needs INDUSTRY TAILWINDS ADVANTAGES OF COMMUNITY - BASED CLINICS RISING INVESTMENTS IN ONCOLOGY CARE ▪ ~$177B market expected to grow to ~$31

  15. Slide 15: Resulting in an Increasing Need for Clinical Care

    15 Resulting in an Increasing Need for Clinical Care Demographic trends, secular tailwinds, and fragmented community - based oncology practices facing pricing pressure will drive increased demand for oncology services and favor national oncology networks with scale ▪ The number of cancer cases throu

  16. Slide 16: AON Has Multiple Levers for Growth

    16 AON Has Multiple Levers for Growth ▪ Significant growth embedded within existing business • Existing physician base will grow as AON drives deeper penetration of ancillaries and new physicians join practices that are alr eady part of the AON network (i.e., physician recruitment) • AON invested he

  17. Slide 17: Financial Summary

    17 $5 $25 $15 $36 $0 $5 $10 $15 $20 $25 $30 $35 $40 2019 2020 2021 Q2 '22 RR $28 $47 $73 $73 $40 $100 $132 159 $67 $147 $205 $233 $0 $50 $100 $150 $200 $250 $300 2019 2020 2021 Q2 '22 RR Adjusted Corporate Overhead Clinical Salaries & Benefits $72 $172 $220 $269 $0 $50 $100 $150 $200 $250 $300 $350

  18. Slide 18: Reconciliation of Non-GAAP Financials

    18 Reconciliation of Non - GAAP Financials NOTE: Non - GAAP financials are unaudited figures. 1) Includes accrual for Washington state B&O tax. 2) Calculated as Q2 2022 results multiplied by 4 but adjusted to pro rate for $1 million annual Medicare payment received during Q2 of each year. 2 Fiscal Y

  19. Slide 19: Appendix

    Appendix Opportunities Corp. q AON Digital Transformation

  20. Slide 20: Case Studies: Successful AON Partnership

    20 Case Studies: Successful AON Partnership THE CHALLENGE ▪ Overcome limited resources and achieve economies of scale to improve overall quality performance and optimize the use of resources ▪ To optimize patient care and ramp up services without increasing costs to the patient, Genesis joined AON ▪

  21. Slide 21: Case Studies: Successful AON Partnership (Cont.)

    21 Case Studies: Successful AON Partnership (Cont.) THE CHALLENGE ▪ Provide cost effective community - based care and realize the full potential of clinical drug prescriptions without having to sacrifice autonomy ▪ Enables Zangmeister to implement VBC and OCM models and strengthen its revenue stream

  22. Slide 22: Summary Risk Factors

    Summary Risk Factors q AON Digital Transformation Opportunities Corp.

  23. Slide 23: Summary Risk Factors

    23 Summary Risk Factors All references to “AON,” “we,” “us,” “our” or the “Company” refer to the business of American Oncology Network, LLC and its a ffi liates. The risks presented below are certain of the general risks related to the business of the Company, Digital Transformation Opportunities Co

  24. Slide 24: Summary Risk Factors (Cont.)

    24 Summary Risk Factors (Cont.) Operational Risks and Risks Related to Our Industries: ▪ A pandemic, epidemic or outbreak of an infectious disease in the United States or worldwide, including the outbreak of the no vel strain of coronavirus disease, COVID - 19, could adversely affect our business, f

  25. Slide 25: Summary Risk Factors (Cont.)

    25 Summary Risk Factors (Cont.) Risks Related to AON and the Potential Transaction: ▪ The Company will incur significant legal, accounting, and other costs and obligations as a result of being a newly public com pan y. ▪ Provisions in the combined company’s charter and Delaware law may inhibit a tak

  26. Slide 26: Summary Risk Factors (Cont.)

    26 Summary Risk Factors (Cont.) Risks Related to DTOC and the Potential Transaction (Continued): ▪ The ability of DTOC and AON to consummation the Potential Transaction may be adversely affected by the status of the equity a nd debt markets. ▪ Past performance by entities affiliated with DTOC or its

Digital Transformation Opportunities — SPAC Merger (October 2022) on 6ix